- Isaralgagene civaparvovec, or ST-920, continued to be generally well tolerated across four dose cohorts in the nine treated patients in the dose escalation phase. - All nine patients exhibited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback